Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brachytherapy for brain tumors.

Todd W Vitaz1, Peter C Warnke, Viviane Tabar

  • 1Neurosurgical Service Memorial Sloan-Kettering Cancer Center, New York, NY, USA. tvitaz@niky.com

Journal of Neuro-Oncology
|June 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resection plus stereotactic radiosurgery versus stereotactic radiosurgery alone and control of brain metastasis-induced seizures.

Journal of neurosurgery·2026
Same author

Impact of Cortisol Circadian Rhythm on Psychological Well-Being in Treated Cushing Syndrome: A Cross-Sectional Study.

The Journal of clinical endocrinology and metabolism·2026
Same author

Care pathways for asymptomatic brain metastases: comparison of healthcare utilization, costs, and outcomes in outpatient versus acute settings.

Journal of neuro-oncology·2026
Same author

Modulation of WNT and FGF18 enhances yield and subtype identity of hPSC-derived midbrain dopamine neurons.

The Journal of clinical investigation·2026
Same author

Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment.

Neuro-oncology practice·2026
Same author

Primitive neuronal component is a frequent finding among IDH-mutant astrocytomas with RB1 alterations.

Acta neuropathologica·2026
Same journal

Optimizing the Stupp protocol for treatment of glioblastoma: eliminating age bias, enhancing treatment timing, use of stereotactically-guided sequential boost, and dexamethasone dosing.

Journal of neuro-oncology·2026
Same journal

Gamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors.

Journal of neuro-oncology·2026
Same journal

Real-time confocal imaging for evaluation of dose-dependent effects of gamma knife radiosurgery on U87 glioblastoma cell line.

Journal of neuro-oncology·2026
Same journal

Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.

Journal of neuro-oncology·2026
Same journal

Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties.

Journal of neuro-oncology·2026
Same journal

Fractionated stereotactic radiotherapy (fSRT) for symptomatic WHO grade 1 cavernous sinus meningiomas: long-term local control, clinical response, and toxicity outcomes.

Journal of neuro-oncology·2026
See all related articles

Brachytherapy, a direct radioactive implant for malignant brain tumors, showed initial promise but failed to improve survival in randomized trials. Despite mixed results, it remains a treatment option for various brain tumors.

Area of Science:

  • Neuro-oncology
  • Radiation Oncology
  • Neurosurgery

Background:

  • Malignant brain tumors present a significant challenge for neurooncologists seeking to prolong patient survival.
  • Brachytherapy, a form of radiotherapy involving direct radioactive source implantation, was investigated as an adjuvant treatment.
  • Initial single-institution studies suggested promising outcomes for brachytherapy.

Purpose of the Study:

  • To review the rationale, radiobiology, complications, indications, and results of brachytherapy for brain tumors.
  • To emphasize the application of brachytherapy in treating glial tumors.
  • To provide a comprehensive overview of brachytherapy's role in neuro-oncology.

Main Methods:

  • Review of numerous studies on brachytherapy for brain tumors.

Related Experiment Videos

  • Analysis of brachytherapy's application in various tumor types, including gliomas, meningiomas, and metastases.
  • Focus on data from randomized studies and single-institution experiences.

    • Main Results:

    • Brachytherapy demonstrated promising results in initial single-institution studies.
    • Two randomized studies failed to show a significant survival advantage with brachytherapy.
    • Despite limitations, brachytherapy continues to be utilized in various centers worldwide.

    Conclusions:

    • Brachytherapy's efficacy in significantly prolonging survival for malignant brain tumors remains debated due to conflicting study results.
    • The technique is still employed for specific brain tumors, including gliomas, meningiomas, and metastases.
    • Further research and careful patient selection are crucial for optimizing brachytherapy's role in neuro-oncology.